Paper32007145
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.
Lu R and 34 others. Lancet, 2020. Cited by 7,379 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Papers, record 32007145. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32007145
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.
- PubMed
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Betacoronavirus | Major topic |
| Coronavirus Infections | Major topic |
| Genome, Viral | Major topic |
| Pneumonia, Viral | Major topic |
| Receptors, Virus | Major topic |
| Bronchoalveolar Lavage Fluid | |
| COVID-19 | |
| China | |
| DNA, Viral | |
| Disease Reservoirs | |
| Genomics | |
| High-Throughput Nucleotide Sequencing | |
| Humans | |
| Phylogeny | |
| SARS-CoV-2 | |
| Sequence Alignment |
Source PubMed
Trials10
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT04343768 | An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial | Background | ClinicalTrials.gov | |
| NCT04352556 | COVID19-hematological Malignancies: the Italian Hematology Alliance | Background | ClinicalTrials.gov | |
| NCT04402203 | Study on Safety and Efficacy of Favipiravir (Favipira) for COVID-19 Patient in Selected Hospitals of Bangladesh | Background | ClinicalTrials.gov | |
| NCT04407182 | Safety and Efficacy of Viusid and Asbrip in Hospitalized Patients Infected by SARS-Cov-2 With COVID-19 | Background | ClinicalTrials.gov | |
| NCT04414904 | Determining the Reproductive Health of Men Post-COVID-19 Infection | Background | ClinicalTrials.gov | |
| NCT04420260 | Primary Prevention of Infection by COVID-19 in Workers | Background | ClinicalTrials.gov | |
| NCT04516746 | Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults | Background | ClinicalTrials.gov | |
| NCT04568525 | Passive Microwave Radiometry (MWR) and AI for COVID-19 Complications Early Diagnostics of Lungs | Background | ClinicalTrials.gov | |
| NCT04987853 | Clinical, Functional, Immunological and Genetic Factors on the Severity of the Course of Coronavirus Infection | Results | ClinicalTrials.gov | |
| NCT04998253 | Effects in Oxygenation and Hypoxic Pulmonary Vasoconstriction in ARDS Secondary to SARS-CoV2 | Results | ClinicalTrials.gov |
Comments and corrections2
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 32,325,130 | Bayesian phylodynamic inference on the temporal evolution and global transmission of SARS-CoV-2. | https://conductscience.org/library/papers/32325130 | PubMed |
| Comment in | 32,346,073 | COVID-19: towards understanding of pathogenesis. | https://conductscience.org/library/papers/32346073 | PubMed |
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19,451,168 | Fast and accurate short read alignment with Burrows-Wheeler transform. | Bioinformatics | 2009 | https://conductscience.org/library/papers/19451168 | PubMed |
| 2 | 25,211,075 | Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26. | Cell Host Microbe | 2014 | https://conductscience.org/library/papers/25211075 | PubMed |
| 3 | 29,506,019 | Parallelization of MAFFT for large-scale multiple sequence alignments. | Bioinformatics | 2018 | https://conductscience.org/library/papers/29506019 | PubMed |
| 4 | 22,205,743 | Evidence for a common evolutionary origin of coronavirus spike protein receptor-binding subunits. | J Virol | 2012 | https://conductscience.org/library/papers/22205743 | PubMed |
| 5 | 9,847,317 | Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. | J Virol | 1999 | https://conductscience.org/library/papers/9847317 | PubMed |
| 6 | 28,709,419 | The clinical and virological features of the first imported case causing MERS-CoV outbreak in South Korea, 2015. | BMC Infect Dis | 2017 | https://conductscience.org/library/papers/28709419 | PubMed |
| 7 | 27,899,674 | CDD/SPARCLE: functional classification of proteins via subfamily domain architectures. | Nucleic Acids Res | 2017 | https://conductscience.org/library/papers/27899674 | PubMed |
| 8 | 34,594,763 | A Novel Coronavirus Genome Identified in a Cluster of Pneumonia Cases - Wuhan, China 2019-2020. | China CDC Wkly | 2020 | https://conductscience.org/library/papers/34594763 | PubMed |
| 9 | 14,562,877 | Pathogenicity of turkey coronavirus in turkeys and chickens. | Avian Dis | 2003 | https://conductscience.org/library/papers/14562877 | PubMed |
| 10 | 31,986,261 | A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. | Lancet | 2020 | https://conductscience.org/library/papers/31986261 | PubMed |
| 11 | 15,018,127 | SARS: epidemiology. | Respirology | 2003 | https://conductscience.org/library/papers/15018127 | PubMed |
| 12 | 27,521,523 | A dynamic compartmental model for the Middle East respiratory syndrome outbreak in the Republic of Korea: A retrospective analysis on control interventions and superspreading events. | J Theor Biol | 2016 | https://conductscience.org/library/papers/27521523 | PubMed |
| 13 | 12,958,366 | Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. | Science | 2003 | https://conductscience.org/library/papers/12958366 | PubMed |
| 14 | 31,978,945 | A Novel Coronavirus from Patients with Pneumonia in China, 2019. | N Engl J Med | 2020 | https://conductscience.org/library/papers/31978945 | PubMed |
| 15 | 23,831,647 | Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26. | Nature | 2013 | https://conductscience.org/library/papers/23831647 | PubMed |
| 16 | 27,468,951 | MERS-CoV spike protein: Targets for vaccines and therapeutics. | Antiviral Res | 2016 | https://conductscience.org/library/papers/27468951 | PubMed |
| 17 | 29,618,817 | Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin. | Nature | 2018 | https://conductscience.org/library/papers/29618817 | PubMed |
| 18 | 23,075,143 | Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. | N Engl J Med | 2012 | https://conductscience.org/library/papers/23075143 | PubMed |
| 19 | 27,578,435 | Structure, Function, and Evolution of Coronavirus Spike Proteins. | Annu Rev Virol | 2016 | https://conductscience.org/library/papers/27578435 | PubMed |
| 20 | 24,451,623 | RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies. | Bioinformatics | 2014 | https://conductscience.org/library/papers/24451623 | PubMed |
Cited by6,175
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7,379 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,961,523 | Comparative analysis of production and kinetic assay conditions and parameters for SARS-CoV-2 main protease (Mpro): a systematic review. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42961523 | PubMed |
| 42,903,918 | Systemic profiling of immune responses in healthy adults vaccinated with an RBD-targeting COVID-19 mRNA vaccine. | Hlife | 2025 | https://conductscience.org/library/papers/42903918 | PubMed |
| 42,903,890 | Modeling viral evolution: A novel SIRSVIDE framework with application to SARS-CoV-2 dynamics. | Hlife | 2024 | https://conductscience.org/library/papers/42903890 | PubMed |
| 42,890,211 | Early functional maturation of anti-Spike antibodies predicts efficient SARS-CoV-2 RNA clearance. | Front Immunol | 2026 | https://conductscience.org/library/papers/42890211 | PubMed |
| 42,851,570 | "Nowhere to go" qualitative exploration of social workers' perspectives on violence against women in Jordan during the COVID-19 pandemic. | Front Glob Womens Health | 2026 | https://conductscience.org/library/papers/42851570 | PubMed |
| 42,847,964 | Crystal structures of the N-terminal and C-terminal domains of the SARS-CoV-2 nucleocapsid protein. | Acta Crystallogr F Struct Biol Commun | 2026 | https://conductscience.org/library/papers/42847964 | PubMed |
| 42,799,060 | Omicron SARS-CoV-2 maternal infection is associated with favorable fetomaternal outcomes and fewer placental vascular malperfusion lesions compared with previous variants. | AJOG Glob Rep | 2026 | https://conductscience.org/library/papers/42799060 | PubMed |
| 42,798,753 | COVID-19 and female reproductive health: pathophysiological mechanisms and clinical reproductive outcomes. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42798753 | PubMed |
| 42,781,491 | Chimeric SARS-CoV-2 vaccine vectors stably incorporating the functional glycoprotein of VSV. | iScience | 2026 | https://conductscience.org/library/papers/42781491 | PubMed |
| 42,776,426 | Discovery of a new SARS-CoV-2 Mpro inhibitor from a natural product and natural product-like compound database using in silico and in vitro studies. | Mol Divers | 2026 | https://conductscience.org/library/papers/42776426 | PubMed |
| 42,774,152 | Multi-epitope vaccine targeting SARS-CoV-2 omicron S and N proteins promotes enhanced immunity: a computational approach. | Front Immunol | 2026 | https://conductscience.org/library/papers/42774152 | PubMed |
| 42,758,812 | Secreted ORF8 reprograms macrophages to enhance SARS-CoV-2 infection of lung epithelial cells. | Sci Adv | 2026 | https://conductscience.org/library/papers/42758812 | PubMed |
| 42,655,159 | Structural and Mechanistic Perspectives on SARS-CoV-2 Nonstructural Protein 14-Mediated Cap Formation and Drug Discovery. | Microorganisms | 2026 | https://conductscience.org/library/papers/42655159 | PubMed |
| 42,643,508 | Comparative systemic pathogenicity and host tropism of ancestral SARS-CoV-2, Delta, and Omicron EG.5 variants in K18-hACE2 mice. | Front Immunol | 2026 | https://conductscience.org/library/papers/42643508 | PubMed |
| 42,587,639 | SARS-CoV-2 Point-of-Care Testing Modalities: Integrating Molecular, Immunological, Biosensor, and AI Approaches. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/42587639 | PubMed |
| 42,578,668 | Revisiting endothelial tropism of SARS-CoV-2 using a cell-specific hACE2 mouse model. | Microbiol Spectr | 2026 | https://conductscience.org/library/papers/42578668 | PubMed |
| 42,566,544 | Direct visualization of RNA virus and evaluation of drug effect in living cells by catalytically transformable DNA cube. | Sci Adv | 2026 | https://conductscience.org/library/papers/42566544 | PubMed |
| 42,566,492 | Directed evolution of a stem-helix-targeting antibody enables MERS-CoV cross-neutralization through enhanced binding affinity. | PLoS Pathog | 2026 | https://conductscience.org/library/papers/42566492 | PubMed |
| 42,549,977 | SARS-CoV-2 Spike Peptides Trigger Nociceptive Responses Through Spinal TLR4 Pathways. | Eur J Pain | 2026 | https://conductscience.org/library/papers/42549977 | PubMed |
| 42,530,330 | ACE2-fused nanobody targeting a cryptic RBD epitope broadly neutralizes SARS-like viruses. | J Virol | 2026 | https://conductscience.org/library/papers/42530330 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ACE2 | 59,272 | PubTator's text mining | https://conductscience.org/library/genes/59272 | NCBI Gene |
| DPP4 | 1,803 | PubTator's text mining | https://conductscience.org/library/genes/1803 | NCBI Gene |
| GAPDH | 2,597 | PubTator's text mining | https://conductscience.org/library/genes/2597 | NCBI Gene |
Drugs2
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets | Source |
|---|---|---|---|---|---|
| SEVOFLURANE | CHEMBL1200694 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL1200694 | ChEMBL |
| FENTANYL | CHEMBL596 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL596 | ChEMBL |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32007145
GET https://conductscience.org/api/papers/v1/32007145/authors?page=2